TNKase® (Tenecteplase) is for intravenous administration only. The recommended total dose should not exceed 50 mg and is based upon patient weight.
A single bolus dose should be administered over 5 seconds based on patient   weight.Treatment should be initiated as soon as possible after the onset of   AMI symptoms (see Clinical Studies).
Dose Information Table 
The safety and efficacy of TNKase (tenecteplase)  have only been investigated with concomitant    administration of heparin and aspirin as described in Clinical    Studies.
THE 10 mL SYRINGE WITH TWINPAK™ DUAL CANNULA DEVICE 
NOTE: Read all instructions completely before beginning reconstitution   and administration.
